Physician

Dipak P Shah, M.D.

According to 2025 Medicare claims, Dipak Shah, M.D. (NPI: 1710129341) practices cardiac electrophysiology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is HENRY FORD HEALTH PROVIDENCE HOSPITAL (NPI: 1871554626; TIN: 381358212) and primary practice location at 48075-4818. Shah is affiliated with the St. John Providence ACO, LLC (ACO ID: A5417), participating under the MSSP model.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 606 traditional Medicare patients, billed 1,852 HCPCS/CPT codes, and received $147,219 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,914 prescription claims across 304 beneficiaries totaling $630,301 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 56 records totaling $135,747. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $169,858 and ending at $147,219. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $166,363 to $630,301. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	721	2,090	$169,858
2016	624	2,172	$195,774
2017	683	2,109	$169,309
2018	765	2,262	$184,981
2019	761	2,390	$241,792
2020	609	1,854	$173,039
2021	646	2,062	$212,598
2022	641	1,897	$159,459
2023	591	1,862	$157,209
2024	606	1,852	$147,219

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	187	1,146	$166,363
2016	190	1,275	$210,410
2017	205	1,295	$244,907
2018	254	1,567	$307,750
2019	254	1,667	$381,935
2020	253	1,624	$419,601
2021	267	1,764	$475,670
2022	270	1,705	$459,195
2023	287	1,909	$582,029
2024	304	1,914	$630,301

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	146	240	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	64	89	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	95	123	$48
93280	Programming of dual lead pacemaker system	57	89	$27
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	283	470	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	346	20,975	$390,576
Xarelto	Rivaroxaban	126	8,735	$158,579
Entresto	Sacubitril/Valsartan	14	660	$14,261
Flecainide Acetate	Flecainide Acetate	163	12,072	$7,240
Amiodarone Hcl	Amiodarone Hcl	80	5,658	$3,757

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$14,588	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	20	$121,158	Abbott Laboratories
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dipak P. Shah, M.D.?

Tedicare shows public-source Medicare data for Dipak P. Shah, M.D. (NPI 1710129341), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dipak P. Shah, M.D. have ACO affiliation data?

Dipak P. Shah, M.D. is shown with ACO affiliation data for St. John Providence ACO, LLC (MSSP, ACO ID A5417).

What billing organization is linked to Dipak P. Shah, M.D.?

Dipak P. Shah, M.D. is linked to HENRY FORD HEALTH PROVIDENCE HOSPITAL (billing NPI 1871554626) in the available physician profile data.

Does Dipak P. Shah, M.D. have Open Payments data?

Dipak P. Shah, M.D. has 56 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.